MBA 540 Module One Journal Entry- Exploring Sanofi S.A. in the Pharmaceutical Industry

docx

School

Southern New Hampshire University *

*We aren’t endorsed by this school

Course

540

Subject

Business

Date

Feb 20, 2024

Type

docx

Pages

3

Uploaded by DeaconWaterBuffaloMaster632

Report
Miranda Gabriel MBA 540 Module One Journal Journal Entry: Exploring Sanofi S.A. in the Pharmaceutical Industry Company Overview: Sanofi S.A. is a prominent pharmaceutical industry player dedicated to improving health worldwide. With its global headquarters in Paris, France, Sanofi has strategically positioned itself as a leading pharmaceutical company internationally. The company's commitment extends beyond geographical boundaries, emphasizing innovation and research to address global health challenges. Products and Services: Sanofi's diverse portfolio spans a wide range of pharmaceutical products and services. It is recognized for its contributions in therapeutic areas such as diabetes, oncology, immunology, and vaccines. The company strongly emphasizes research and development, consistently introducing innovative medications and treatment solutions. Customer Base: Sanofi serves a dual customer base, catering to both businesses and individuals. The company engages in partnerships, collaborations, and distribution agreements with healthcare providers, institutions, and other pharmaceutical entities on the business front. Simultaneously, Sanofi directly impacts individuals by providing various healthcare solutions, including prescription medications, vaccines, and consumer healthcare products. Current Obstacle:
Over the past year, Sanofi has encountered a notable obstacle in the form of global supply chain disruptions. The COVID-19 pandemic has exposed vulnerabilities in supply chain networks, affecting the timely production and distribution of pharmaceutical products. Like many in the industry, Sanofi faced challenges securing raw materials, navigating transportation disruptions, and ensuring a consistent supply of medicines to meet global demand. Impact on Revenue and Market Share: The supply chain disruptions substantially threaten Sanofi's revenue and market share. Delays in production and distribution can lead to product shortages, potentially resulting in revenue loss and diminished market presence. Additionally, increased operational costs associated with adapting to these challenges may impact profit margins. As competition in the pharmaceutical industry remains fierce, any setback in maintaining a robust supply chain could result in a decline in market share, affecting Sanofi's overall competitiveness. In conclusion, Sanofi S.A.'s resilience in overcoming obstacles, such as supply chain disruptions, will be crucial in sustaining its position as a global pharmaceutical leader. The ability to adapt to evolving challenges while prioritizing innovation will be vital in ensuring the company's continued success in the dynamic landscape of the pharmaceutical industry. Citations Ousbey, J. (2021, August 26).  Rising to the Challenge . PharmaTimes. https://www.pharmatimes.com/magazine/2021/julyaugust_2021/rising_to_the_challenge
Sanofi. (n.d.). About us. Retrieved December 10, 2023, from  https://www.sanofi.com/en/about-us https://www-mergentonline-com.ezproxy.snhu.edu/companydetail.php? compnumber=53258&pagetype=synopsis (I was unsure how to cite this. Still researching) 
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help